Corporate Banner
Satellite Banner
Pharma Outsourcing
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - October 2012


Pharma Commercial Excellence in CEE, CIS, SEE & Turkey

04 Oct 2012 - 05 Oct 2012 - Budapest, Hungary



Bookmark and Share


At this 2-day event attendees will have a unique chance to interact with the pharmaceutical specialists from concerned regions. The representatives from AstraZeneca, Sanofi, Merck, Novartis, Teva etc. will share their best practices in the form of presentations and case studies. 

During the 2-stream program on both days, 20 experts speakers will provide participants with governmental perspective, industry and regulatory insights, and physicians' and payers' perspectives. 

The special block, involved into the first conference day, will bring the deeper insight into the HTA processes throughout the regions. Russian, Slovak, Serbian, Polish, Swedish and Turkish perspectives will be introduced.

How to maintain and maximize competitive advantage in the region? How to optimize interactions between the key stakeholders? What are the ways to predict and meet customer needs? These are only few of many questions that will be answered at Fleming Europe's conference.

For more information request the detailed agenda http://pharma.flemingeurope.com/pharma-excellence/request-agenda




Further information
Scientific News
Drug to Treat Alcohol Use Disorder Shows Promise Among Drinkers With High Stress
The findings suggest that potential future studies with drugs targeting vasopressin blockade should focus on populations of people with AUD who also report high levels of stress.
Scientists Find Lethal Vulnerability in Treatment-Resistant Lung Cancer
The study describes how the drug Selinexor killed lung cancer cells and shrank tumors in mice when used against cancers driven by the aggressive and difficult-to-treat KRAS cancer gene.
Advanced Lymphoma in Remission After T-Cell Therapy
63% of trial participants who recieved two-drug combination chemo plus intermediate dose of engineered T cells went into complete remission.
New Treatment for Immune Cancers
Clinical trial shows new drug holds promise for treating advanced mastocytosis.
Sickle Cell Gene Therapy Passes Test
Researchers found a precision-engineered gene therapy virus reduced sickle-induced red-cell damage in mice with sickle cell disease.
Opening Door to Oesophageal Cancer Targeted Treatments
Scientists have discovered that oesophageal cancer can be classified into three different subtypes.
Vitamin C May Boost Leukemia Treatment
Studies show that supplementing an epigenetic cancer drug with vitamin C enhanced the drug's effectiveness.
Inovio Launches Zika Vaccine Trial
Inovio launches Zika vaccine trial in midst of Puerto Rico epidemic to explore early signals of vaccine efficacy.
New Hope for Zika Treatment Found in Large-Scale Screen of Existing Drugs
Johns Hopkins researchers join collaborative group to screen 6,000 existing drugs in hopes of finding treatments for Zika Virus infection
FINCH Filgotinib Phase 3 Program Initiated
Galapagos NV reports the initiation of the FINCH global Phase 3 program in rheumatoid arthritis patient populations.
Scroll Up
Scroll Down
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,000+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!